Does cisapride, as a 5HT 4 receptor agonist, aggravate the severity of TNBS-induced colitis in rat?

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Motavallian, Azadeh ^a   Minaiyan, Mohsen ^a   Rabbani, Mohammad ^a   Mahzouni, Parvin ^b   Andalib, Sasan ^c   Abed, Alireza ^a   Babavalian, Mohammad Reza ^d  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CISAPRIDE; DEXAMETHASONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; SEROTONIN 4 RECEPTOR; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DESCENDING COLON; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INTESTINE NECROSIS; INTESTINE WALL; MALE; NONHUMAN; PATHOGENESIS; RAT;

EID: 84864957079     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/362536     Document Type: Article

References (37)

1. Sands B. E., Therapy of inflammatory bowel disease Gastroenterology 2000 118 2 S68 S82
2. Podolsky D. K., Inflammatory bowel disease The New England Journal of Medicine 2002 347 417 429 (Pubitemid 34851835)
3. Baumgart D. C., Sandborn W. J., Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 2007 369 9573 1641 1657 (Pubitemid 46722637)
4. Forbes E., Murase T., Yang M., Matthaei K. I., Lee J. J., Lee N. A., Foster P. S., Hogan S. P., Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase Journal of Immunology 2004 172 9 5664 5675 (Pubitemid 38542070)
5. Grisham M. B., Molecular and cellular aspects of intestinal inflammation: clinical implications in inflammatory bowel disease Inflammatory Bowel Diseases 2000 1 1 14
6. Langmead L., Rampton D. S., Review article: complementary and alternative therapies for inflammatory bowel disease Alimentary Pharmacology and Therapeutics 2006 23 3 341 349 (Pubitemid 43382014)
7. Cloz-Tayarani I., Petit-Bertron A. F., Venters H. D., Cavaillon J. M., Differential effect of serotonin on cytokine production in lipopolysaccharide- stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors International Immunology 2003 15 2 233 240 (Pubitemid 36267115)
8. Kim D. Y., Camilleri M., Serotonin: a mediator of the brain-gut connection American Journal of Gastroenterology 2000 95 10 2704 2709
9. Gershon M. D., Tack J., The serotonin signaling system: from basic understanding to drug development for functional GI disorders Gastroenterology 2007 132 1 397 414 (Pubitemid 46127672)
10. Costedio M. M., Hyman N., Mawe G. M., Serotonin and its role in colonic function and in gastrointestinal disorders Diseases of the Colon and Rectum 2007 50 3 376 388 (Pubitemid 46394454)
11. Kris M. G., Ondansetron: a specific serotonin antagonist for the prevention of chemotherapy-induced vomiting Important Advances in Oncology 1994 165 177
12. De Ponti F., Pharmacology of serotonin: what a clinician should know Gut 2004 53 10 1520 1535 (Pubitemid 39272827)
13. McCleane G. J., Suzuki R., Dickenson A. H., Does a single intravenous injection of the 5HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled cross-over study Anesthesia and Analgesia 2003 97 5 1474 1478 (Pubitemid 37310150)
14. Hrycaj P., Serotonin type 3 receptor antagonist tropisetron in the treatment of chronic inflammatory rheumatic conditionspreliminary clinical experience Scandinavian Journal of Rheumatology 2004 33 119 55 58 (Pubitemid 39180190)
15. Motavallian-Naeini A., Andalib S., Rabbani M., Mahzouni P., Afsharipour M., Minaiyan M., Validation and optimization of experimental colitis induction in rats using 2,4, 6-trinitrobenzene sulfonic acid Research in Pharmaceutical Sciences 2012 7 3 159 169
16. Linden D. R., Chen J. X., Gershon M. D., Sharkey K. A., Mawe G. M., Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis American Journal of Physiology 2003 285 1 G207 G216
17. Hoffman J. M., Tyler K., MacEachern S. J., Balemba O. B., Johnson A. C., Brooks E. M., Zhao H., Swain G. M., Moses P. L., Galligan J. J., Sharkey K. A., Greenwoodvan Meerveld B., Mawe G. M., Activation of colonic mucosal 5-HT 4 receptors accelerates propulsive motility and inhibits visceral hypersensitivity Gastroenterology 2012 142 4 844 854
18. Coates M. D., Mahoney C. R., Linden D. R., Sampson J. E., Chen J., Blaszyk H., Crowell M. D., Sharkey K. A., Gershon M. D., Mawe G. M., Moses P. L., Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome Gastroenterology 2004 126 7 1657 1664 (Pubitemid 38736329)
19. Fiebich B. L., Akundi R. S., Seidel M., Geyer V., Haus U., Mller W., Stratz T., Candelario-Jalil E., Expression of 5-HT3A receptors in cells of the immune system Scandinavian Journal of Rheumatology 2004 33 119 9 11 (Pubitemid 39180179)
20. Stefulj J., Jernej B., Cicin-Sain L., Rinner I., Schauenstein K., mRNA expression of serotonin receptors in cells of the immune tissues of the rat Brain, Behavior, and Immunity 2000 14 3 219 224 (Pubitemid 32280876)
21. Ghia J. E., Li N., Wang H., Collins M., Deng Y., El-Sharkawy R. T., Cté F., Mallet J., Khan W. I., Serotonin has a key role in pathogenesis of experimental colitis Gastroenterology 2009 137 5 1649 1660
22. Motavallian-Naeini A., Minaiyan M., Rabbani M., Mahzuni P., Anti-inflammatory effect of ondansetron through 5HT3 receptors on TNBS-induced coloitis in rat Experimental and Clinical Sciences Journal 2012 11 30 44
23. Minaiyan M., Ghannadi A. R., Etemad M., Mahzouni P., A study of the effects of Cydonia oblonga Miller (Quince) on TNBS-induced ulcerative colitis in rats Research in Pharmaceutical Sciences 2012 7 2 103 110
24. Tari A., Sumii K., Yoshihara M., Ohgoshi H., Teshima H., Fukuhara I., Haruma K., Kajiyama G., Tanaka K., Miyoshi A., Miyachi Y., Effect of cisapride on the concentrations of -endorphinlike immunoreactivity and substance P-like immunoreactivity in the rat gastrointestinal tract Biochemical and Biophysical Research Communications 1987 147 3 1162 1169 (Pubitemid 17150589)
25. Garca-Garayoa E., Monge A., Roca J., Del Ro J., Lasheras B., VB20B7, a novel 5-HT-ergic agent with gastrokinetic activityII. Evaluation of the gastroprokinetic activity in rats and dogs Journal of Pharmacy and Pharmacology 1997 49 1 66 73 (Pubitemid 27051033)
26. Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallace J. L., Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 1989 96 3 795 803 (Pubitemid 19057602)
27. Ballester I., Daddaoua A., Lpez-Posadas R., Nieto A., Surez M. D., Zarzuelo A., Martnez-Augustin O., De Medina F. S., The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats British Journal of Pharmacology 2007 151 2 206 215 (Pubitemid 46763048)
28. Cooper H. S., Murthy S. N. S., Shah R. S., Sedergran D. J., Clinicopathologic study of dextran sulfate sodium experimental murine colitis Laboratory Investigation 1993 69 2 238 250 (Pubitemid 23262505)
29. Dieleman L. A., Palmen M. J. H. J., Akol H., Bloemena E., Pea A. S., Meuwissen S. G. M., Van Rees E. P., Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines Clinical and Experimental Immunology 1998 114 3 385 391 (Pubitemid 28539597)
30. Bradley P. P., Priebat D. A., Christensen R. D., Rothstein G., Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker Journal of Investigative Dermatology 1982 78 3 206 209 (Pubitemid 12171880)
31. Pereira Nacife V., de Nazaré Correia Soeiro M., Novaes Gomes R., D'Avila H., Caire Castro-Faria Neto H., de Nazareth Leal Meirelles M., Morphological and biochemical characterization of macrophages activated by carrageenan and lipopolysaccharide in vivo Cell Structure and Function 2004 29 2 27 34 (Pubitemid 39206717)
32. Zheng L., Gao Z. Q., Wang S. X., A chronic ulcerative colitis model in rats World Journal of Gastroenterology 2000 6 1 150 152 (Pubitemid 30093089)
33. Dohi T., Fujihashi K., Type 1 and 2 T helper cell-mediated colitis Current Opinion in Gastroenterology 2006 22 6 651 657 (Pubitemid 44624533)
34. Ajuebor M. N., Hogaboam C. M., Kunkel S. L., Proudfoot A. E. I., Wallace J. L., The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat Journal of Immunology 2001 166 1 552 558 (Pubitemid 32038476)
35. Cloz-Tayarani I., Changeux J. P., Nicotine and serotonin in immune regulation and inflammatory processes: a perspective Journal of Leukocyte Biology 2007 81 3 599 606
36. Esmaily H., Hosseini-Tabatabaei A., Rahimian R., Khorasani R., Baeeri M., Barazesh-Morgani A., Yasa N., Khademi Y., Abdollahi M., On the benefits of silymarin in murine colitis by improving balance of destructive cytokines and reduction of toxic stress in the bowel cells Central European Journal of Biology 2009 4 2 204 213
37. Maunder R., Mediators of stress effects in inflammatory bowel disease: not the usual suspects Journal of Psychosomatic Research 2000 48 6 569 577